{"doc_desc":{"title":"Organisation de la r\u00e9habilitation respiratoire chez le patient post COVID-19 porteur de s\u00e9quelles. Evaluation et indication th\u00e9rapeutique de la t\u00e9l\u00e9-r\u00e9habilitation versus la r\u00e9habilitation classique.","idno":"FRESH-PEF73830-fr","producers":[{"name":"","affiliation":""}]},"study_desc":{"title_statement":{"idno":"FRESH-PEF73830-fr","IDno":{"metadata_no":[{"agency":"PEF","code":"73830"},{"agency":"FReSH","code":"FRESH-PEF73830"}]},"title":"Organisation de la r\u00e9habilitation respiratoire chez le patient post COVID-19 porteur de s\u00e9quelles. Evaluation et indication th\u00e9rapeutique de la t\u00e9l\u00e9-r\u00e9habilitation versus la r\u00e9habilitation classique.","alternate_title":"REHABCOVID"},"study_authorization":{"agency":[{"name":"Autre"}]},"authoring_entity":[{"type":"investigator","name":"Jean-Marc;VALLIER","PILabo":"","affiliationName":null,"extlink":[{"title":"ORCID","uri":"0000-0001-7187-2576","role":"pi id"},{"title":"IdRef","uri":"070464502","role":"pi id"},{"title":"","uri":"","role":"organisation id"},{"title":"","uri":"","role":"labo id"}],"email":"vallier@univ-tln.fr","isContact":"Oui"}],"oth_id":[{"name":""}],"production_statement":{"prod_place":"Portail Epid\u00e9miologie France (PEF)","producers":[{"name":"CENTRE HOSPITALIER INTERCOMMUNAL TOULON \/ LA SEYNE-SUR-MER","extlink":[{"title":"ROR","uri":"https:\/\/ror.org\/04wqvjr21","role":"sponsor id"},{"title":"SIREN","uri":"268300126","role":"sponsor id"}],"role":"sponsor"}],"funding_agencies":[{"name":""}]},"distribution_statement":{"contact":[{"name":"Jean-Marc;VALLIER","email":"vallier@univ-tln.fr","type":"contact","affiliationName":null,"contactPointLabo":"","extlink":[]}]},"study_info":{"keywords":[],"topics":[{"topic":"Pneumologie","vocab":"health theme","extLink":[{"title":"ESV","uri":"http:\/\/data.europa.eu\/8mn\/euroscivoc\/f6e18c52-6087-4662-904c-5c4b8174e40e"},{"title":"MeSH","uri":"http:\/\/id.nlm.nih.gov\/mesh\/D015272"}]},{"topic":"Maladies de l'appareil respiratoire","vocab":"cim-11","extLink":[{"uri":"http:\/\/id.who.int\/icd\/entity\/197934298","title":"CIM-11"}]},{"topic":"COVID-19","vocab":"cim-11","extLink":[{"uri":"http:\/\/id.who.int\/icd\/entity\/1730556128","title":"CIM-11"}]}],"purpose":"Comparer l\u2019efficacit\u00e9 de deux m\u00e9thodes de r\u00e9habilitation respiratoire sur la capacit\u00e9 physique des patients : un programme de 4 semaines de t\u00e9l\u00e9-r\u00e9habilitation respiratoire (TRR) vs un programme de r\u00e9habilitation respiratoire (RR) classique sur la diminution des s\u00e9quelles existant chez des patients post COVID-19.","abstract":"","coll_dates":[{"start":"","end":""}],"nation":[{"name":"France","abbreviation":"fr","extLink":{"vocab":"ISO","vocabURI":"fr"}}],"geog_coverage":"['Provence - Alpes - C\u00f4te d\\'Azur']","analysis_unit":"Individus","universe":"{\n    \"level_sex_clusion_I\": [\n        {\n            \"value\": \"Masculin\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D008297\"\n            }\n        },\n        {\n            \"value\": \"F\u00e9minin\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D005260\"\n            }\n        }\n    ],\n    \"level_age_clusion_I\": [\n        {\n            \"value\": \"Adulte (19 \u00e0 24 ans)\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D055815\"\n            }\n        },\n        {\n            \"value\": \"Adulte (25 \u00e0 44 ans)\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D000328\"\n            }\n        },\n        {\n            \"value\": \"Adulte (45 \u00e0 64 ans)\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D008875\"\n            }\n        },\n        {\n            \"value\": \"Personne \u00e2g\u00e9e (65 \u00e0 79 ans)\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D000368\"\n            }\n        },\n        {\n            \"value\": \"Grand \u00e2ge (80 ans et plus)\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D000369\"\n            }\n        }\n    ],\n    \"level_type_clusion_I\": \"Patients\",\n    \"level_type_clusion_other\": \"\",\n    \"clusion_I\": \"1. Sujets de plus de 18 ans. 2. Sujets ayant contract\u00e9 le COVID-19 objectiv\u00e9 par un test RT-PCR positif et\\\/ou la pr\u00e9sence d\u2019anticorps. 3. Sujets ayant eu une prescription m\u00e9dicale de r\u00e9habilitation respiratoire. 4. Sujet ayant le mat\u00e9riel informatique et la couverture r\u00e9seau n\u00e9cessaires pour r\u00e9aliser une visioconf\u00e9rence. 5. Sujets ayant au moins une des s\u00e9quelles post-COVID-19 suivantes : - Dyspn\u00e9e de repos ou d\u2019exercice objectiv\u00e9e par l\u2019\u00e9chelle mMRC (modified Medical Research Council) avec un score sup\u00e9rieur ou \u00e9gal \u00e0 2. (Vestbo et al, 2013) - Hyperventilation objectiv\u00e9e par le questionnaire de Nijmegen avec un score sup\u00e9rieur ou \u00e9gal \u00e0 23\\\/64 (Vandixhoorn et Duivenvoordent, 1985 ; Sauty et Prosper, 2008) - Intol\u00e9rance \u00e0 l\u2019effort objectiv\u00e9e par le 1min-STS (test de lever de chaise en 1 min) selon les normes par \u00e2ge et par sexe \u00e9tablies par Strassmann et al (2013). - Fatigue anormale objectiv\u00e9e par le MFI-20 (Multidimensional Fatigue Inventory) valid\u00e9 en fran\u00e7ais par Gentile et al (2003) selon les normes par \u00e2ge et sexe \u00e9tablies par Schwarz et al (2003). - Etat d\u2019anxi\u00e9t\u00e9 ou de d\u00e9pression objectiv\u00e9 par le HADS (Hospital Anxiety and Depression scale) valid\u00e9e en fran\u00e7ais par Roberge et al (2013) selon les normes par \u00e2ge et par sexe \u00e9tablies par Boc\u00e9r\u00e9an et Ducret (2014) 6. Affili\u00e9 ou ayant droit d\u2019un r\u00e9gime de s\u00e9curit\u00e9 sociale.\",\n    \"clusion_E\": \"\"\n}","data_kind":"['Donn\u00e9es cliniques','Donn\u00e9es rapport\u00e9es par le participant de l&#x27;\u00e9tude','Donn\u00e9es paracliniques']","quality_statement":{"standards":[{"name":"","committee":"","governance":""}],"other_quality_statement":""}},"study_development":{"development_activity":[]},"method":{"data_collection":{"time_method":"","frequency":"","sampling_procedure":"['{\"concept\":{\"vocabURI\":\"Other\",\"vocab\":\"CESSDA\"},\"value\":\"Autre\"}']","sample_frame":{"frame_unit":{"unit_type":""}},"coll_mode":["{\"concept\":{\"vocabURI\":\"Transcription\",\"vocab\":\"CESSDA\"},\"value\":\"Transcription et saisie d\u2019informations dans un enregistrement structur\u00e9\"}","{\"concept\":{\"vocabURI\":\"Interview\",\"vocab\":\"CESSDA\"},\"value\":\"Entretien avec le participant (dont clinique)\"}"],"research_instrument":"","sources":[],"target_sample_size":"< 500 individus","response_rate":"118 sujets (59 patients dans le groupe RR et 59 patients dans le groupe TRR)"},"method_notes":"Etude observationnelle","study_class":"Inconnu","notes":[{"subject":"research type","values":["Etude observationnelle"]}]},"data_access":{"dataset_availability":{"access_place":"","complete":"","status":"{\"value\":\"A d\u00e9finir\",\"extLink\":[]}"},"dataset_use":{"restrictions":"","conditions":"","conf_dec":[{"txt":""}],"spec_perm":[{"txt":"","required":""}],"contact":[{"name":""}],"deposit_req":"","cit_req":""},"notes":""}},"additional":{"IsImport":true,"versionLang":"fr","originLang":"fr","autoTranslation":false,"status":"imported","creationDate":"27-11-2020","lastUpdatedAuto":null,"lastUpdatedManual":"23-04-2021","isContributorPI":"Non","contributorName":"","contributorAffiliation":"","addTeamMember":"","obtainedAuthorization":{"otherAuthorizingAgency":[""]},"relatedDocument":[],"regulatoryRequirements":{"conformityDeclaration":""},"fundingAgent":{"fundingAgentType":[],"otherFundingAgentType":[]},"sponsor":{"sponsorType":["Public (France)"],"otherSponsorType":[""]},"governance":{"committee":""},"collaborations":{"networkConsortium":""},"theme":{"complementaryInformation":"","RareDiseases":""},"activeFollowUp":{"isActiveFollowUp":"","followUpModeOther":""},"interventionalStudy":{"researchPurpose":[],"trialPhase":[],"interventionalStudyModel":"","isClinicalTrial":"","otherResearchPurpose":""},"isInclusionGroups":"","allocation":{"allocationMode":"","allocationUnit":""},"masking":{"maskingType":"","blindedMaskingDetails":[]},"arms":[],"intervention":[],"inclusionGroups":[],"collectionProcess":{"collectionModeDetails":"","collectionModeOther":""},"dataCollection":{"inclusionStrategyOther":"","samplingModeOther":"","recruitmentSourceOther":"","otherDocumentation":""},"dataCollectionIntegration":{"isDataIntegration":"Non"},"geographicalCoverage":{"geoDetail":""},"dataTypes":{"clinicalDataDetails":"","biologicalDataDetails":"","isDataInBiobank":"","biobankContent":[],"biobankContentOther":"","dataTypeOther":""},"variableDictionnary":{"variableDictionnaryAvailable":"","variableDictionnaryLink":""},"dataQuality":{"otherDocumentation":""},"mockSample":{"mockSampleAvailable":"","mockSampleLocation":""},"thirdPartySource":{"otherSourceType":[]},"isHealthTheme":"Oui","fileDscr":{"fileTxt":{"fileCitation":{"titlStmt":{"IDno":[]}}}}},"schematype":"survey"}